This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Sep;3(9):478-9.

doi: 10.1038/ncpcardio0635.

OASIS-6: should patients with acute ST-segment elevation myocardial infarction be treated with fondaparinux?

Lori-Ann Linkins¹, Jeffrey I Weitz

Affiliations

PMID: 16932763
DOI: 10.1038/ncpcardio0635

Comment

OASIS-6: should patients with acute ST-segment elevation myocardial infarction be treated with fondaparinux?

Lori-Ann Linkins et al. Nat Clin Pract Cardiovasc Med. 2006 Sep.

. 2006 Sep;3(9):478-9.

doi: 10.1038/ncpcardio0635.

Authors

Lori-Ann Linkins¹, Jeffrey I Weitz

Affiliation

¹ McMaster University, Hamilton, ON, Canada. jweitz@thrombosis.hhscr.org

PMID: 16932763
DOI: 10.1038/ncpcardio0635

No abstract available

PubMed Disclaimer

Comment on

Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial.
Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB, Budaj A, Peters RJ, Bassand JP, Wallentin L, Joyner C, Fox KA; OASIS-6 Trial Group. Yusuf S, et al. JAMA. 2006 Apr 5;295(13):1519-30. doi: 10.1001/jama.295.13.joc60038. Epub 2006 Mar 14. JAMA. 2006. PMID: 16537725 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.